← Back to Clinical Trials
Recruiting NCT06116552

NCT06116552 More and Less Social Comprehension

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT06116552
Status Recruiting
Phase
Sponsor University of Kansas Medical Center
Condition Autism Spectrum Disorder
Study Type INTERVENTIONAL
Enrollment 50 participants
Start Date 2023-07-10
Primary Completion 2025-07

Trial Parameters

Condition Autism Spectrum Disorder
Sponsor University of Kansas Medical Center
Study Type INTERVENTIONAL
Phase N/A
Enrollment 50
Sex ALL
Min Age 9 Years
Max Age 12 Years
Start Date 2023-07-10
Completion 2025-07
Interventions
More Social StoriesLess Social Stories

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

Brief Summary

The goal of this early Phase 1 clinical trial is to assess if the social content of a story impacts autistic children's listening comprehension of stories. The main questions this study aims to answer are: * Does removing social content from a story improve listening comprehension in autistic children? * Does listening comprehension of more social versus less social stories differentially predict performance on a standardized reading comprehension measure? Participants will listen to more social and less social stories while viewing accompanying pictures and answer comprehension questions about the stories and complete a standardized assessment of reading comprehension. In addition, participants complete measures of their nonverbal cognition, hearing status, autism severity, language abilities, and social communication abilities to help characterize individual differences in participants.

Eligibility Criteria

Inclusion Criteria: * Has a community or educational autism diagnosis (based on parent report); * Is between the ages of 9;0 to 12;11 (years; months); * Uses verbal phrase-level spoken language (based on parent report). Exclusion Criteria: * Speaks more than one language (based on parent report); * Has a known chromosomal abnormality (e.g., Fragile X syndrome, Down syndrome; based on parent report); * Has an intellectual impairment or cognitive disability (IQ \< 70; based on parent report); * Has Cerebral palsy (based on parent report); * Uncorrected visual impairments (based on parent report); * Minimal spoken language or no phrase spoken language (based on parent report or clinical observation).

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology